Vivace Therapeutics Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 6

Employees
  • Latest Deal Type

  • Series C

  • Latest Deal Amount

  • $30M

  • Investors

  • 8

Vivace Therapeutics General Information

Description

Developer of a small molecule drug discovery and development firm intended to bring novel therapies to treat cancer patients. The company is built on innovative science in novel pathways and leverages research from leading academic laboratories by developing therapeutics that could work alone or in combination with other drugs, enabling healthcare professionals to help patients to conquer cancer.

Contact Information

Website
www.vivacetherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 2929 Campus Drive
  • Suite 150
  • San Mateo, CA 94403
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivace Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 16-Dec-2020 $30M 0000 00000 Completed Startup
2. Early Stage VC (Series B) 28-Jun-2017 0000 0000 0000 Completed Startup
1. Early Stage VC (Series A) 20-Jan-2015 $15M $15M 0000 Completed Startup
To view Vivace Therapeutics’s complete valuation and funding history, request access »

Vivace Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A 15,000,000 $0.001000 $0.08 $1 $1 1x $1 29.87%
To view Vivace Therapeutics’s complete cap table history, request access »

Vivace Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a small molecule drug discovery and development firm intended to bring novel therapies to treat cancer pati
Drug Discovery
San Mateo, CA
6 As of 2023
0000
0000 0000-00-00
00000000000 0000

000000

r sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut lab
0000 000000000
San Carlos, CA
00 As of 0000
00000
000000000 00000

000000

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vivace Therapeutics Competitors (57)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apexigen Formerly VC-backed San Carlos, CA 00 00000 000000000 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000 Formerly VC-backed Boston, MA 00 00000 000000&0 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
You’re viewing 5 of 57 competitors. Get the full list »

Vivace Therapeutics Patents

  • 33

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Vivace Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4061364-A1 Heteroaryl compounds Pending 20-Nov-2019 0000000000
AU-2020257207-A1 Bicyclic compounds Pending 16-Apr-2019 0000000000
CA-3137025-A1 Bicyclic compounds Pending 16-Apr-2019 0000000000
EP-3956033-A1 Bicyclic compounds Pending 16-Apr-2019 0000000000
EP-3956033-A4 Bicyclic compounds Pending 16-Apr-2019 C07D305/06 0
To view Vivace Therapeutics’s complete patent history, request access »

Vivace Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Sofie Qiao Ph.D Co-Founder, President, Chief Executive Officer and Board Member
Bin Liu Ph.D Scientific Co-Founder
Kun-Liang Guan Ph.D Scientific Co-Founder
Andrei Konradi Ph.D Head of Chemistry
Leonard Post Ph.D Chief Scientific Officer & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Vivace Therapeutics Board Members (7)

Name Representing Role Since
Edward Hu Vivace Therapeutics Board Member 000 0000
Jun Wu Vivace Therapeutics Board Member 000 0000
Leonard Post Ph.D Self Chief Scientific Officer & Board Member 000 0000
Norman Zhou Ph.D Self Board Member 000 0000
Sofie Qiao Ph.D Vivace Therapeutics Co-Founder, President, Chief Executive Officer and Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Vivace Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivace Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
Boxer Capital Venture Capital Minority 000 0000 000000 0
RA Capital Management Hedge Fund Minority 000 0000 000000 0
Cenova Capital Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial